Please login to the form below

Not currently logged in

Armando Anido appointed CEO of NuPathe

Will lead company as it develops single-use migraine patch

Former Auxilium Pharmaceuticals president and CEO Armando Anido has been appointed as the new CEO of US biopharma NuPathe.

Anido replaces NuPathe's founder Jane Hollingsworth who has resigned from the position two years after being named Ernst & Young's Entrepreneur of the Year.

At the forefront of Anido's tasks will be to lead the company as it develops lead product candidate NP1010 – a single-use transdermal patch for the treatment of migraine.

In addition, NuPathe has two products in development that make use of its long-acting delivery technology that allows delivery of therapeutic levels of medication over a period of months with a single dose.

These comprise NP201 for the continuous symptomatic treatment of Parkinson's disease and NP202, for the long-term treatment of schizophrenia and bipolar disorder.

Anido has more than 30 years' experience in senior biopharma positions, including his five years in charge of Auxilium. Under his leadership, sales grew from $42m in 2005 to more than $260m in 2011.

Prior to this role, Anido served as executive VP, sales and marketing, at MedImmune and prior to that, in senior sales and marketing positions at GlaxoWellcome and Lederle Laboratories.

His time at GlaxoWellcome involved responsibility for the commercialisation of the migraine, epilepsy and depression businesses in the US, setting Anido up well for NuPathe.

"NuPathe has developed a highly innovative and differentiated product for the treatment of migraine," said Anido. "This product innovation, combined with a large population of underserved migraine patients and an outstanding commercial team, builds the foundation required for a successful launch.”

26th July 2012


Featured jobs

Subscribe to our email news alerts


Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

Beyond the event
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...